The ornithine decarboxylase inhibitor, difluoromethylornithine, inhibits casein kinase II activity, c-Myc expression and normal human keratinocyte proliferation

Arch Dermatol Res. 2002 Jan;293(11):590-3. doi: 10.1007/s00403-001-0278-7.

Authors

M Praskova¹, S Kalenderova, L Miteva, Y Poumay, V Mitev

Affiliation

¹ Department of Biochemistry, University of Medicine, Sofia, Bulgaria.

PMID: 11876528
DOI: 10.1007/s00403-001-0278-7

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Casein Kinase II
Cell Division / drug effects
Cells, Cultured
Eflornithine / pharmacology*
Enzyme Inhibitors / pharmacology*
Humans
Keratinocytes / cytology*
Ornithine Decarboxylase Inhibitors*
Protein Serine-Threonine Kinases / antagonists & inhibitors*
Proto-Oncogene Proteins c-myc / antagonists & inhibitors*

Substances

Enzyme Inhibitors
Ornithine Decarboxylase Inhibitors
Proto-Oncogene Proteins c-myc
Casein Kinase II
Protein Serine-Threonine Kinases
Eflornithine